Endocrine Society GUIDELINES Bundle (free trial)

Diabetes and Pregnancy

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/327552

Contents of this Issue

Navigation

Page 6 of 13

5 Table 1. Diagnostic Criteria for Overt Diabetes and Gestational Diabetes at the First Prenatal Visit (Before 13 Weeks Gestation or As Soon As Possible Thereafter) for Those Women Not Known to Already Have Diabetes a Diagnosis Fasting Plasma Glucose, b mg/dL (mmol/L) Untimed (Random) Plasma Glucose, b mg/dL (mmol/L) HbA1c, c % Overt diabetes (type 1, type 2, or other) ≥126 (≥7.0) ≥200 (≥11.1) ≥6.5 Gestational diabetes 92-125 (5.1-6.9) NA NA NA, not applicable. a ese criteria for the diagnosis of overt diabetes in early pregnancy are congruent with those of the ADA and differ somewhat from those of the IADPSG. b Testing should use plasma glucose analyzed at a laboratory, not capillary blood glucose analyzed with a blood glucose meter. c Performed using a method that is certified by the NGSP and standardized to the DCCT reference assay. Table 2. Diagnostic Criteria for Overt Diabetes and Gestational Diabetes Using a 2-Hour 75-g OGTT at 24-28 Weeks Gestation a Diagnosis Fasting Plasma Glucose, b mg/dL (mmol/L) 1-h Value, mg/dL (mmol/L) 2-h Value, mg/dL (mmol/L) Overt diabetes (type 1, type 2, or other) ≥126 (≥7.0) NA ≥200 (≥11.1) Gestational diabetes 92-125 (5.1-6.9) ≥180 (≥10.0) 153-199 (8.5-11.0) NA, not applicable. a ese criteria for diagnosing overt diabetes based on the results of the 24-28-week glucose tolerance test differ somewhat from those of the ADA and the IADPSG. b Testing should use plasma glucose analyzed at a laboratory, not capillary blood glucose analyzed with a blood glucose meter.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Diabetes and Pregnancy